Aptus Pharma Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 425 as of 08 May 16:01 . The p/e ratio of Aptus Pharma Ltd changed from 0 to 0 over 5 quarters. This represents a CAGR of 0.0% The p/e ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 to 0 over 4 quarters. This represents a CAGR of -100.00% The market cap of Aptus Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The market cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The revenue of Aptus Pharma Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The ebitda of Aptus Pharma Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The net profit of Aptus Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 4.57% The dividend payout of Aptus Pharma Ltd changed from 0 % to 0 % over 5 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 5 quarters. This represents a CAGR of -100.00% .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Aptus Pharma Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Aptus Pharma Ltd is 305 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,961 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Aptus Pharma Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 8, 2026, the Aptus Pharma Ltd stock price is INR ₹445.0. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4759.55.

How do dividend payouts of Aptus Pharma Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.